These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34998206)

  • 1. RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer.
    Hulstaert E; Levanon K; Morlion A; Van Aelst S; Christidis AA; Zamar R; Anckaert J; Verniers K; Bahar-Shany K; Sapoznik S; Vandesompele J; Mestdagh P
    Neoplasia; 2022 Feb; 24(2):155-164. PubMed ID: 34998206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review.
    Hulstaert E; Morlion A; Levanon K; Vandesompele J; Mestdagh P
    Gynecol Oncol; 2021 Feb; 160(2):633-642. PubMed ID: 33257015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of benign peritoneal fluid- and ovarian cancer ascites-derived extracellular vesicle RNA biomarkers.
    Yamamoto CM; Oakes ML; Murakami T; Muto MG; Berkowitz RS; Ng SW
    J Ovarian Res; 2018 Mar; 11(1):20. PubMed ID: 29499737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA expression profile changes in the peripheral blood of monozygotic discordant twins for epithelial ovarian carcinoma: potential new biomarkers for early diagnosis and prognosis of ovarian carcinoma.
    Tuncer SB; Erdogan OS; Erciyas SK; Saral MA; Celik B; Odemis DA; Turkcan GK; Yazici H
    J Ovarian Res; 2020 Aug; 13(1):99. PubMed ID: 32854743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
    Barnabas GD; Bahar-Shany K; Sapoznik S; Helpman L; Kadan Y; Beiner M; Weitzner O; Arbib N; Korach J; Perri T; Katz G; Blecher A; Brandt B; Friedman E; Stockheim D; Jakobson-Setton A; Eitan R; Armon S; Brand H; Zadok O; Aviel-Ronen S; Harel M; Geiger T; Levanon K
    Mol Cell Proteomics; 2019 May; 18(5):865-875. PubMed ID: 30760538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.
    Gao Y; Zhou N; Liu J
    Cancer Control; 2024; 31():10732748241255548. PubMed ID: 38764160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of circulating cell free RNA as a biomarker in cancer.
    Cheung KWE; Choi SR; Lee LTC; Lee NLE; Tsang HF; Cheng YT; Cho WCS; Wong EYL; Wong SCC
    Expert Rev Mol Diagn; 2019 Jul; 19(7):579-590. PubMed ID: 31215265
    [No Abstract]   [Full Text] [Related]  

  • 9. Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression.
    Chang L; Ni J; Zhu Y; Pang B; Graham P; Zhang H; Li Y
    Theranostics; 2019; 9(14):4130-4140. PubMed ID: 31281536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer.
    Balla A; Bhak J; Biró O
    Mol Cell Probes; 2022 Dec; 66():101871. PubMed ID: 36283501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicle-based liquid biopsy holds great promise for the management of ovarian cancer.
    Zheng X; Li X; Wang X
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188395. PubMed ID: 32698041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cf-miRNA as a more appropriate surrogate liquid biopsy marker than cfDNA for ovarian cancer.
    Gahlawat AW; Witte T; Sinn P; Schott S
    Sci Rep; 2023 Apr; 13(1):5503. PubMed ID: 37015943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in ovarian cancer: recent advances on circulating tumor cells and circulating tumor DNA.
    Giannopoulou L; Kasimir-Bauer S; Lianidou ES
    Clin Chem Lab Med; 2018 Jan; 56(2):186-197. PubMed ID: 28753534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.
    Terp SK; Stoico MP; Dybkær K; Pedersen IS
    Clin Epigenetics; 2023 Feb; 15(1):24. PubMed ID: 36788585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis.
    Karimi F; Azadbakht O; Veisi A; Sabaghan M; Owjfard M; Kharazinejad E; Dinarvand N
    Med Oncol; 2023 Aug; 40(9):265. PubMed ID: 37561363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer.
    Li G; Han L; Ren F; Zhang R; Qin G
    J Cell Physiol; 2019 Dec; 234(12):22071-22081. PubMed ID: 31152442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
    Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
    Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer.
    Dou YD; Huang T; Wang Q; Shu X; Zhao SG; Li L; Liu T; Lu G; Chan WY; Liu HB
    Biochem Biophys Res Commun; 2018 Jan; 496(1):191-198. PubMed ID: 29307835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.